Clinical Trial Update: A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL) [Phase 2]

View source ↗

Summary

Two-stage Phase 2 trial of A-007 topical gel in high-grade cervical intraepithelial lesions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Dysplasia
• Cervical Intraepithelial Neoplasia

Drugs mentioned

• A-007 Topical Gel

Snippet

Sponsor: Tigris Pharmaceuticals | Conditions: Cervical Intraepithelial Neoplasia, Uterine Cervical Dysplasia | Phase 2 | Status: COMPLETED